Publications by authors named "Helen Ye"

Claim this Profile
H
Hospital nurses perceived challenges and opportunities in the care of people with dementia: A mixed-methods systematic review.
Helen Mei-Yan Ye, Lily Dongxia Xiao, Shahid Ullah, Rita Hui-Chen Chang

J Clin Nurs· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Assessment and Treatment of Inpatient Cancer-Related Pain with Acupuncture: Development of a Manual.
Jennifer Ashby, Miria Toveg, Helen Ye, Lee Hullender Rubin, Sanjay Reddy

Med Acupunct· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Usability of Electronic Health Records for Whole Systems Integrative Medicine Practitioners.
Helen Ye, Denise Bowden, Jennifer Ashby, Miria Toveg, Sanjay Reddy

J Altern Complement Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors.
Paul A Renhowe, Sabina Pecchi, Cynthia M Shafer, Timothy D Machajewski, Elisa M Jazan, Helen Ye, Jayesh Vora

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.
Daniel E Lopes de Menezes, Kimberly Denis-Mize, Yan Tang, Helen Ye, John C Kunich

J Immunother· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia.
Daniel E Lopes de Menezes, Jing Peng, Evelyn N Garrett, Sharianne G Louie, Sang H Lee, Helen Ye

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
Sang Hoon Lee, Daniel Lopes de Menezes, Jayesh Vora, Alex Harris, Helen Ye

Clin Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis